Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
06/2002
06/27/2002US20020081626 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample
06/26/2002EP1216251A2 Regioselective synthesis of rapamycin derivatives
06/26/2002EP1216250A1 Thienoisoxazolyl and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists
06/26/2002EP1216249A2 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
06/26/2002EP1216244A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d 4? antagonists
06/26/2002CN1355806A Process for preparation of herbicidal derivatives
06/26/2002CN1086706C Pyrido [3,2,1,i,j][3,1] benzoxazine derivatives
06/25/2002US6410550 Aryl fused azapolycyclic compounds
06/25/2002US6410534 Anticancer agents
06/25/2002US6410480 Plant safening agents and growth regulators for controlling weeds and grasses; post/preemergence herbicides
06/25/2002US6410301 Genetically engineered cells; for use in generating carcinogenic agents
06/20/2002WO2002048153A1 Process for preparing substance gm-95
06/20/2002WO2002048150A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
06/20/2002WO2002048138A1 Antimicrobial quinolones
06/20/2002WO2002048113A1 Cyclization process step in the making of quinolones and naphthyridines
06/20/2002US20020077491 Reacting core molecules with a mixture of nucleophilic building blocks in a reaction vessel to form a library of compounds
06/20/2002US20020077345 Cis-substituted aminocycloalkylpyrrolidine derivatives
06/20/2002US20020077321 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis
06/20/2002CA2429951A1 Antimicrobial quinolones
06/19/2002EP1215201A2 Process for the preparation of aryloctanoyl amides
06/19/2002EP1214326A1 Inhibitors of prenyl-protein transferase
06/19/2002EP1105395B1 Photocyclized rapamycins
06/19/2002EP1042326B1 Novel acronycine derivatives, preparation method and pharmaceutical compositions
06/19/2002CN1354747A 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity
06/18/2002US6407118 Antitumor agents; side effect reduction
06/18/2002US6407092 Tetracyclic azepinoindole compounds
06/18/2002CA2057786C Amino and nitro containing tricyclic compounds useful as inhibitors or ace
06/18/2002CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
06/13/2002WO2002046197A1 Macroheterocylic compounds useful as kinase inhibitors
06/13/2002WO2002046166A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
06/13/2002US20020072612 7a-alkoxy-4H-pyrano [3,2-d] -oxazol-2 (3H) -one and process for producing the same
06/13/2002US20020072528 Are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit T-helper-type 2 immune response; useful for therapy of viral and neoplastic diseases
06/13/2002US20020072525 Aryl fused azapolycyclic compounds
06/13/2002US20020072524 Aryl fused azapolycyclic compounds
06/13/2002CA2431187A1 Macroheterocylic compounds useful as kinase inhibitors
06/12/2002EP1213281A1 Novel amide derivatives
06/12/2002EP1212331A1 28-epirapalogs
06/12/2002EP1212330A1 Androgen receptor modulator compounds and methods
06/12/2002EP0625982B1 4-oxo- and 4h-imidazo(5,1-c)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents
06/12/2002CN1353717A Tetracyclic progesterone receptor modulator compounds and methods
06/12/2002CN1353702A Adamantane derivatives
06/12/2002CN1353608A Use of macrolide compounds for treatment of dry eye
06/11/2002US6403591 1-azatricyclic-4-benzylpiperazines
06/11/2002US6403583 Anticoagulant agents for treatment and prevention of thromboembolic disorders.
06/11/2002CA2262692C Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
06/06/2002WO2002044302A1 Novel red fluorescent material and organic electroluminescent device containing same
06/06/2002WO2002044194A1 L-nucleic acid derivatives and processes for the synthesis thereof
06/06/2002WO2002044180A1 Lactam compounds and medicinal use thereof
06/06/2002WO2002044153A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
06/06/2002US20020068747 Inhibitors of prenyl-protein transferase
06/06/2002CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
06/05/2002EP1211254A1 Process for the preparation of benzoxazine derivatives and intermediates therefor
06/05/2002EP1210351A2 Method for separating lactone-containing high-molecular weight compounds
06/05/2002EP1210350A1 Water soluble sdz-rad esters
06/05/2002EP1210332A1 Bleach boosting components, compositions and laundry methods
06/05/2002EP1209975A1 Herbicidal composition
06/05/2002EP1209974A2 Heterocyclic spiro compounds as pesticides
06/05/2002EP0788501B1 Protein kinase inhibitors for treatment of neurological disorders
06/05/2002EP0642516B1 Macrocyclic immunomodulators
06/04/2002US6399780 Kinase inhibitors; anticancer agents
06/04/2002US6399626 Useful in inducing immunosuppression and in treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, vascular disease
06/04/2002US6399625 1-oxorapamycins
06/04/2002US6399593 Contraceptives
06/04/2002CA2024071C Pyrido [2, 3-b] [1,5]benzoxazepin (and thiazepin)-5 (6h)-ones and-thiones and their use in prevention or treatment of hiv infection
05/2002
05/30/2002WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
05/30/2002WO2000066225A8 Contraceptive compositions containing cyclic carbamates and amide derivatives
05/30/2002US20020065295 Novel polyketide derivatives
05/30/2002US20020065284 Dipeptide derivatives
05/30/2002US20020065268 New compounds, their preparation and use
05/30/2002US20020065267 Compounds, their preparation and use
05/29/2002CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors
05/29/2002CN1085667C Substituted tetracylic azepine derivatives having affinity for 5-HT2 receptors
05/28/2002US6395809 Salt formation with hydrochloric, sulfuric, or phosphoric acid; automobiles, electronics
05/28/2002US6395724 Multibinding inhibitors of cyclooxygenase-2
05/23/2002WO2002040478A1 Dehalogeno compounds
05/23/2002WO2002040009A1 Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity
05/23/2002WO2002040000A2 Use of cci-779 as an antineoplastic agent
05/23/2002WO2001087884A3 Polyketide derivatives
05/23/2002US20020061913 Bicyclic amine derivatives
05/23/2002US20020061907 Macrolide compound, a dissolution/absorption promoter, a pharmaceutical base, and optionally a compatibilizing agent and/or a thickener; topical for skin disorders
05/23/2002US20020061906 Aerosol compositions
05/23/2002US20020061905 Ethers of 7-desmethylrapamycin
05/23/2002US20020061904 Hydroxyesters of 7-desmethylrapamycin
05/23/2002US20020061903 1-oxorapamycins
05/23/2002US20020061880 New compounds, their preparation and use
05/23/2002US20020061876 Compounds, their preparation and use
05/22/2002EP1207162A1 7a-alkoxy-4H-pyrano-[3,2-d]-oxazol-2(3H)-one and process for producing the same
05/22/2002EP1207161A1 Novel isoindole derivatives
05/22/2002EP1206493A2 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
05/22/2002EP1206474A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
05/22/2002EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones
05/22/2002EP1206469A1 Antibacterial heterobicyclic substituted phenyl oxazolidinones
05/22/2002CN1350527A Aminomethylpyrrolidine derivatives having aromatic substituents
05/22/2002CN1085212C Rapamycin 42-oximes and hydroxylamines
05/22/2002CN1085206C Benzofurazan compounds which enhance AMPA receptor activity
05/21/2002US6391905 4,5-dihydro-8-methylthio-2-phenylfuro(3,4-e)benzothiazole-6-ca rboxylic acid, for example; anti-matrix metalloprotease activity; for bone diseases such as osteoporosis, rheumatoid arthritis, cancer metastasis
05/21/2002US6391900 Antitumor agents
05/21/2002CA2082636C Process for the preparation of sulfonylpristinamycin iib
05/16/2002WO2002038563A2 Condensed pyrazindione derivatives as pde inhibitors
05/16/2002WO2002002090A3 Inhibitors of copper-containing amine oxidases